Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis (CBTd-E)
Schizophrenia, Psychotic Disorders, Delusions
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Delusions, Schizophrenia, Cognitive Behavior Therapy, Emotion, Emotion regulation, self-esteem, sleep quality, Efficacy of change
Eligibility Criteria
Treatment Group:
Inclusion Criteria:
- Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder (DSM-5 diagnosis)
- Delusions present in the last three months (score of at least three in three out of six PSYRATS scores)
- problems in at least two out of three possible mediators: sleep problems (ISI sum score > 7), low self-esteem (score > 3in the BCSS negative self scale) and/or problems in emotion regulation (score in all items < 4)
- fluent in German language
- agree to participate
- estimated general intelligence of at least 70 in the German Mehrfachwahlwortschatztest (MWT-B)
- no present suicidality
Exclusion Criteria:
- acute suicidal tendency
- comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month
- taking of Benzodiazepines
Sites / Locations
- University of Marburg, Faculty of Clinical Psychology and Psychotherapy
- University of Hamburg, Faculty of Clinical Psychology and Psychotherapy
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
CBTd-E
Treatment as Usual
Experimental: emotion-oriented Cognitive Behavior Therapy focused on delusions for patients with schizophrenia-spectrum disorders and delusions. The therapeutical intervention follows a treatment-manual consisting of two modules. Patients work on two modules every week for 25 weeks in a row. Module I comprises psychoeducation on emotions, training radical acceptance of emotions and mindfulness, cognitive and behavioral strategies in order to change negative emotions and in order to foster positive emotions and suggestions for life-style changes (positive activities, sports, stress reduction). In the second module, the focus is on self-acceptance. Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.
Patients who are randomized and assigned to the Wait-list receive treatment as usual (regular visits to a physicist every third month and antipsychotic medication). After six month the waiting list patients receive the treatment specified above.